Total Payments
$99,085
2024 Payments
$22,181
Companies
33
Transactions
226
Medicare Patients
1,642
Medicare Billing
$329,782
Payment Breakdown by Category
Other$64,945 (65.5%)
Consulting$24,551 (24.8%)
Food & Beverage$5,850 (5.9%)
Travel$3,715 (3.7%)
Education$24.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61,345 | 49 | 61.9% |
| Consulting Fee | $24,551 | 18 | 24.8% |
| Food and Beverage | $5,850 | 144 | 5.9% |
| Travel and Lodging | $3,715 | 11 | 3.7% |
| Honoraria | $3,600 | 1 | 3.6% |
| Education | $24.08 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66,751 | 78 | $0 (2024) |
| Novo Nordisk Inc | $6,218 | 2 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $3,785 | 4 | $0 (2021) |
| Eli Lilly and Company | $3,520 | 1 | $0 (2022) |
| Lilly USA, LLC | $3,300 | 5 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $2,972 | 1 | $0 (2020) |
| Abbott Laboratories | $2,915 | 23 | $0 (2024) |
| Akcea Therapeutics, Inc. | $2,292 | 2 | $0 (2020) |
| Alnylam Pharmaceuticals Inc. | $1,679 | 10 | $0 (2024) |
| Medtronic, Inc. | $1,509 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,181 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20,081) |
| 2023 | $26,371 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,971) |
| 2022 | $25,763 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,594) |
| 2021 | $14,629 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,106) |
| 2020 | $7,850 | 11 | C. R. Bard, Inc. & Subsidiaries ($2,972) |
| 2019 | $1,216 | 28 | Medtronic, Inc. ($541.67) |
| 2018 | $429.55 | 17 | Medtronic Vascular, Inc. ($158.89) |
| 2017 | $645.07 | 17 | Abbott Laboratories ($353.25) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $74.73 | General |
| Category: Heart Failure | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,425.00 | General |
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,650.00 | General |
| 09/16/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $149.38 | General |
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $68.74 | General |
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $333.82 | General |
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $192.66 | General |
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,425.00 | General |
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $440.00 | General |
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $286.07 | General |
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.52 | General |
| 07/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,425.00 | General |
| 05/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.96 | General |
| 05/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Heart Failure | ||||||
| 04/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| 04/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| 03/28/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $135.73 | General |
| Category: Heart Failure | ||||||
| 03/13/2024 | Daxor Corporation | BVA-100 (Device) | Food and Beverage | Cash or cash equivalent | $101.56 | General |
| Category: Diagnostic Test | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 395 | 721 | $511,117 | $79,332 |
| 2022 | 9 | 490 | 881 | $640,532 | $98,334 |
| 2021 | 9 | 428 | 722 | $497,696 | $81,456 |
| 2020 | 8 | 329 | 617 | $434,805 | $70,659 |
Total Patients
1,642
Total Services
2,941
Medicare Billing
$329,782
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 75 | 210 | $150,150 | $22,988 | 15.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 45 | 114 | $161,310 | $22,699 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 185 | $101,750 | $21,185 | 20.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 42 | $59,472 | $6,738 | 11.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $14,155 | $2,897 | 20.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 75 | 102 | $14,790 | $1,366 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 16 | $8,800 | $1,181 | 13.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 31 | 33 | $690.00 | $277.20 | 40.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 46 | 125 | $176,875 | $25,892 | 14.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 238 | $170,170 | $22,733 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 177 | $97,350 | $20,283 | 20.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 79 | 81 | $114,696 | $15,079 | 13.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 36 | $26,820 | $6,126 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 35 | $19,250 | $3,237 | 16.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $14,910 | $2,963 | 19.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 84 | 133 | $19,285 | $1,839 | 9.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 11 | 14 | $616.00 | $99.93 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 28 | $560.00 | $82.89 | 14.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 87 | 238 | $165,545 | $23,164 | 14.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 155 | $85,250 | $18,994 | 22.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 64 | 70 | $95,691 | $13,116 | 13.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 23 | 46 | $65,090 | $9,586 | 14.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 36 | 41 | $30,545 | $7,023 | 23.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $24,495 | $4,970 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 20 | $11,000 | $1,907 | 17.3% |
About Dr. Shaline Rao, MD
Dr. Shaline Rao, MD is a Internal Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174724827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shaline Rao, MD has received a total of $99,085 in payments from pharmaceutical and medical device companies, with $22,181 received in 2024. These payments were reported across 226 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($61,345).
As a Medicare-enrolled provider, Rao has provided services to 1,642 Medicare beneficiaries, totaling 2,941 services with total Medicare billing of $329,782. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Washington, DC
- Active Since 05/30/2007
- Last Updated 03/25/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174724827
Products in Payments
- JARDIANCE (Drug) $20,076
- Monoferric (Drug) $3,785
- CARDIOMEMS (Device) $1,247
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $682.40
- ENTRESTO (Drug) $462.53
- Circulatory Support (Device) $353.25
- CardioMEMS HF System (Device) $350.34
- VYNDAQEL (Drug) $211.37
- Barostim Neo System (Device) $188.58
- HeartWare HVAD (Device) $158.89
- MITRACLIP (Device) $149.76
- Veltassa (Drug) $142.36
- LifeVest (Device) $136.22
- BVA-100 (Device) $101.56
- ONPATTRO (Drug) $96.36
- VERQUVO (Drug) $95.38
- Adapta (Device) $89.52
- HeartMate 3 Left Ventricular Dev (Device) $88.57
- Repatha (Biological) $84.39
- CAMZYOS (Drug) $69.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Washington
Lawrence Dubuske, M.d, M.D
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Kavita Patel, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Andrea Singer
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Theo Hodge, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Ashte Collins, M.d, M.D
Internal Medicine — Payments: $837,513
Internal Medicine $837,513
Manish Shah, Md, MD
Internal Medicine — Payments: $456,731
Internal Medicine $456,731